Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area

Toxicology and Applied Pharmacology

Volumn 226, Issue 1, 2008, Pages 14-21

  Chung, Chi Jung ^a   Huang, Chi Jung ^a   Pu, Yeong Shiau ^b   Su, Chien Tien ^c   Huang, Yung Kai ^a   Chen, Ying Ting ^a   Hsueh, Yu Mei ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

8 Hydroxydeoxyguanosine; Urinary arsenic profile; Urothelial carcinoma

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ARSENIC; ARSENIC TRIOXIDE; CACODYLIC ACID; CREATININE; METHANEARSONIC ACID;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLADDER CANCER; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; OXIDATIVE STRESS; URINARY TRACT CARCINOMA;

AGED; ARSENIC; CASE-CONTROL STUDIES; DEOXYGUANOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; SMOKING; URINARY BLADDER NEOPLASMS;

ANIMALIA;

EID: 36849095609     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.08.021     Document Type: Article

References (53)

1. Akagi S., Nagake Y., Kasahara J., Sarai A., Kihara T., Morimoto H., Yano A., Nakao K., Nanba K., Ichikawa H., and Makino H. Significance of 8-hydroxy-2'-deoxyguanosine levels in patients with chronic renal failure. Nephrology 8 (2003) 192-195
2. Akcay T., Saygili I., Andican G., and Yalcin V. Increased formation of 8-hydroxy-2'-deoxyguanosine in peripheral blood leukocytes in bladder cancer. Urol. Int. 71 (2003) 271-274
3. Bates M.N., Rey O.A., Biggs M.L., Hopenhayn C., Moore L.E., Kalman D., Steinmaus C., and Smith A.H. Case-control study of bladder cancer and exposure to arsenic in Argentina. Am. J. Epidemiol. 159 (2004) 381-389
4. Brown K.G., and Ross G.L. Arsenic, drinking water, and health: a position paper of the American Council on Science and Health. Regul. Toxicol. Pharmacol. 36 (2002) 162-174
5. Chen Y.C., Amarasiriwardena C.J., Hsueh Y.M., and Christiani D.C. Stability of arsenic species and insoluble arsenic in human urine. Cancer Epidemiol. Biomark. Prev. 11 (2002) 1427-1433
6. Chen Y.C., Su H.J., Guo Y.L., Hsueh Y.M., Smith T.J., Ryan L.M., Lee M.S., and Christiani D.C. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14 (2003) 303-310
7. Chiou H.Y., Chiou S.T., Hsu Y.H., Chou Y.L., Tseng C.H., Wei M.L., and Chen C.J. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 153 (2001) 411-418
8. Chiou C.C., Chang P.Y., Chan E.C., Wu T.L., Tsao K.C., and Wu J.T. Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin. Chim. Acta 334 (2003) 87-94
9. Dhawan V., and Jain S. Garlic supplementation prevents oxidative DNA damage in essential hypertension. Mol. Cell. Biochem. 275 (2005) 85-94
10. Felix K., Manna S.K., Wise K., Barr J., and Ramesh G.T. Low levels of arsenite activates nuclear factor-kappaB and activator protein-1 in immortalized mesencephalic cells. J. Biochem. Mol. Toxicol. 19 (2005) 67-77
11. Hakim I.A., Harris R.B., Brown S., Chow H.H., Wiseman S., Agarwal S., and Talbot W. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J. Nutr. 133 (2003) 3303S-3309S
12. Hakim I.A., Harris R.B., Chow H.H., Dean M., Brown S., and Ali I.U. Effect of a 4-month tea intervention on oxidative DNA damage among heavy smokers: role of glutathione S-transferase genotypes. Cancer Epidemiol. Biomark. Prev. 13 (2004) 242-249
13. Howard D.J., Ota R.B., Briggs L.A., Hampton M., and Pritsos C.A. Environmental tobacco smoke in the workplace induces oxidative stress in employees, including increased production of 8-hydroxy-2'-deoxyguanosine. Cancer Epidemiol. Biomark. Prev. 7 (1998) 141-146
14. Hsueh Y.M., Huang Y.L., Huang C.C., Wu W.L., Chen H.M., Yang M.H., Lue L.C., and Chen C.J. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J. Toxicol. Environ. Health 54 (1998) 431-444
15. Hu C.W., Pan C.H., Huang Y.L., Wu M.T., Chang L.W., Wang C.J., and Chao M.R. Effects of arsenic exposure among semiconductor workers: a cautionary note on urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine. Free Radic. Biol. Med. 40 (2006) 1273-1278
16. Huang C., Ke Q., Costa M., and Shi X. Molecular mechanisms of arsenic carcinogenesis. Mol. Cell. Biochem. 255 (2004) 57-66
17. IARC. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 84 (2004) 1-477
18. Ichiba M., Maeta Y., Mukoyama T., Saeki T., Yasui S., Kanbe T., Okano J., Tanabe Y., Hirooka Y., Yamada S., Kurimasa A., Murawaki Y., and Shiota G. Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma. Liver Int. 23 (2003) 338-345
19. Irie M., Tamae K., Iwamoto-Tanaka N., and Kasai H. Occupational and lifestyle factors and urinary 8-hydroxydeoxyguanosine. Cancer Sci. 96 (2005) 600-606
20. Kamat C.D., Green D.E., Curilla S., Warnke L., Hamilton J.W., Sturup S., Clark C., and Ihnat M.A. Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration. Toxicol. Sci. 86 (2005) 248-257
21. Karagas M.R., Tosteson T.D., Morris J.S., Demidenko E., Mott L.A., Heaney J., and Schned A. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15 (2004) 465-472
22. Kimura S., Yamauchi H., Hibino Y., Iwamoto M., Sera K., and Ogino K. Evaluation of urinary 8-hydroxydeoxyguanine in healthy Japanese people. Basic Clin. Pharmacol. Toxicol. 98 (2006) 496-502
23. Liu L., Trimarchi J.R., Navarro P., Blasco M.A., and Keefe D.L. Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability, and apoptosis. J. Biol. Chem. 278 (2003) 31998-32004
24. Loft S., and Poulsen H.E. Cancer risk and oxidative DNA damage in man. J. Mol. Med. 74 (1996) 297-312
25. Lynn S., Gurr J.R., Lai H.T., and Jan K.Y. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res. 86 (2000) 514-519
26. Malins D.C., Anderson K.M., Jaruga P., Ramsey C.R., Gilman N.K., Green V.M., Rostad S.W., Emerman J.T., and Dizdaroglu M. Oxidative changes in the DNA of stroma and epithelium from the female breast: potential implications for breast cancer. Cell Cycle 5 (2006) 1629-1632
27. Miyake H., Hara I., Kamidono S., and Eto H. Oxidative DNA damage in patients with prostate cancer and its response to treatment. J. Urol. 171 (2004) 1533-1536
28. Mizoue T., Kasai H., Kubo T., and Tokunaga S. Leanness, smoking, and enhanced oxidative DNA damage. Cancer Epidemiol. Biomark. Prev. 15 (2006) 582-585
29. Nishikawa T., Wanibuchi H., Ogawa M., Kinoshita A., Morimura K., Hiroi T., Funae Y., Kishida H., Nakae D., and Fukushima S. Promoting effects of monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S-transferase placental form positive foci: a possible reactive oxygen species mechanism. Int. J. Cancer 100 (2002) 136-139
30. Pi J., Kumagai Y., Sun G., Yamauchi H., Yoshida T., Iso H., Endo A., Yu L., Yuki K., Miyauchi T., and Shimojo N. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic. Biol. Med. 28 (2000) 1137-1142
31. Pi J., Yamauchi H., Kumagai Y., Sun G., Yoshida T., Aikawa H., Hopenhayn-Rich C., and Shimojo N. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ. Health Perspect. 110 (2002) 331-336
32. Proteggente A.R., England T.G., Rehman A., Rice-Evans C.A., and Halliwell B. Gender differences in steady-state levels of oxidative damage to DNA in healthy individuals. Free Radic. Res. 36 (2002) 157-162
33. Pu Y.S., Yang S.M., Huang Y.K., Chung C.J., Hunag S.K., Chiu W.H., Yang M.H., Chen C.J., and Hsueh Y.M. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol. Appl. Pharmacol. 218 (2007) 99-106
34. Rozalski R., Gackowski D., Roszkowski K., Foksinski M., and Olinski R. The level of 8-hydroxyguanine, a possible repair product of oxidative DNA damage, is higher in urine of cancer patients than in control subjects. Cancer Epidemiol. Biomark. Prev. 11 (2002) 1072-1075
35. Saito S., Yamauchi H., Hasui Y., Kurashige J., Ochi H., and Yoshida K. Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dg) by using ELISA. Res. Commun. Mol. Pathol. Pharmacol. 107 (2000) 39-44
36. Shen J., Deininger P., Hunt J.D., and Zhao H. 8-Hydroxy-2'-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer 109 (2007) 574-580
37. Shi H., Hudson L.G., Ding W., Wang S., Cooper K.L., Liu S., Chen Y., Shi X., and Liu K.J. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem. Res. Toxicol. 17 (2004) 871-878
38. Steinmaus C., Yuan Y., Bates M.N., and Smith A.H. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am. J. Epidemiol. 158 (2003) 1193-1201
39. Steinmaus C., Yuan Y., Kalman D., Atallah R., and Smith A.H. Intraindividual variability in arsenic methylation in a U.S. population. Cancer Epidemiol. Biomark. Prev. 14 (2005) 919-924
40. Steinmaus C., Bates M.N., Yuan Y., Kalman D., Atallah R., Rey O.A., Biggs M.L., Hopenhayn C., Moore L.E., Hoang B.K., and Smith A.H. Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States. J. Occup. Environ. Med. 48 (2006) 478-488
41. Su P.F., Hu Y.J., Ho I.C., Cheng Y.M., and Lee T.C. Distinct gene expression profiles in immortalized human urothelial cells exposed to inorganic arsenite and its methylated trivalent metabolites. Environ. Health Perspect. 114 (2006) 394-403
42. Tapio S., and Grosche B. Arsenic in the aetiology of cancer. Mutat. Res. 612 (2006) 215-246
43. Tseng C.H. An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology 53 (2002) 529-537
44. Tseng C.H., Huang Y.K., Huang Y.L., Chung C.J., Yang M.H., Chen C.J., and Hsueh Y.M. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol. Appl. Pharmacol. 206 (2005) 299-308
45. Valko M., Rhodes C.J., Moncol J., Izakovic M., and Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160 (2006) 1-40
46. Wei M., Wanibuchi H., Morimura K., Iwai S., Yoshida K., Endo G., Nakae D., and Fukushima S. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 23 (2002) 1387-1397
47. Wen C.P., Levy D.T., Cheng T.Y., Hsu C.C., and Tsai S.P. Smoking behaviour in Taiwan, 2001. Tob. Control 14 (2005) i51-i55
48. WHO. Histological Typing of Urinary Bladder Tumours. International Classification of Tumours (1999), World Health Organization, Geneva
49. Wu M.M., Chiou H.Y., Wang T.W., Hsueh Y.M., Wang I.H., Chen C.J., and Lee T.C. Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. Environ. Health Perspect. 109 (2001) 1011-1017
50. Yamanaka K., Kato K., Mizoi M., An Y., Takabayashi F., Nakano M., Hoshino M., and Okada S. The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis. Toxicol. Appl. Pharmacol. 198 (2004) 385-393
51. Yamauchi H., Aminaka Y., Yoshida K., Sun G., Pi J., and Waalkes M.P. Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. Toxicol. Appl. Pharmacol. 198 (2004) 291-296
52. Yoshida T., Yamauchi H., and Fan S.G. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol. Appl. Pharmacol. 198 (2004) 243-252
53. Zhang T.C., Schmitt M.T., and Mumford J.L. Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro. Carcinogenesis 24 (2003) 1811-1817